1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )TABLE 2:Mean DTI metrics in patients with metastatic brain tumors
Patient Diagnosis Peritumoral Signal Abnormality Normal-Appearing White Matter MD (×10−3 mm2/s) FA MD (×10−3 mm2/s) FA 1 Breast carcinoma 0.697 0.244 0.399 0.428 2 Melanoma 0.723 0.244 0.415 0.412 3 Breast carcinoma 0.838 0.149 0.436 0.653 4 Testicular carcinoma 0.811 0.194 0.410 0.471 5 Breast carcinoma 0.743 0.174 0.398 0.369 6 Melanoma 0.701 0.183 0.369 0.508 7 Lung carcinoma 0.908 0.114 0.381 0.338 8 Lung carcinoma 0.639 0.229 0.385 0.400 9 Lung carcinoma 0.789 0.168 0.376 0.428 10 Osteosarcoma 0.943 0.182 0.408 0.362 11 Lung carcinoma 1.002 0.157 0.407 0.356 12 Undifferentiated sarcoma 0.788 0.140 0.387 0.404